4//SEC Filing
LIGAND PHARMACEUTICALS INC 4
Accession 0001247741-04-000034
$LGNDCIK 0000886163operating
Filed
May 25, 8:00 PM ET
Accepted
May 26, 3:02 PM ET
Size
7.3 KB
Accession
0001247741-04-000034
Insider Transaction Report
Form 4
CROSS ALEXANDER D
Director
Transactions
- Sale
Common Stock
2004-05-26$20.00/sh−2,000$40,000→ 8,001 total(indirect: By Trust) - Sale
Common Stock
2004-05-25$19.00/sh−2,000$38,000→ 10,001 total(indirect: By Trust)
Holdings
- 24,494
Common Stock
Footnotes (1)
- [F1]Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 19, 2004.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000886163
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 3:02 PM ET
- Size
- 7.3 KB